Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bey

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric OncologyO Oberlin, G Leverger, H Pacquement, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1986
Abdominal recurrences in Wilms' tumours: a report from the SIOP Wilms' tumour trials and studiesJ M Burgers, M F Tournade, P Bey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Management of mucositis following radiotherapy for head and neck cancers]M Lapeyre, C Charra-Brunaud, M C Kaminsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815)W A Van Sickle, P K Wilson, M W Wannamaker, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 30, 2010
[Is proton beam therapy the future of radiotherapy? Part I: clinical aspects]A Bouyon-Monteau, J-L Habrand, J Datchary, et al.
Journal of Medicinal Chemistry|February 1, 1991
4',5'-unsaturated 5'-halogenated nucleosides. Mechanism-based and competitive inhibitors of S-adenosyl-L-homocysteine hydrolaseE T Jarvi, J R McCarthy, S Mehdi, et al.
British Journal of Cancer|May 18, 2001
Hodgkins diseaseC Ferme, J M Cosset, B Fervers, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Multicenter study on dose escalation with conformal and conventional radiotherapy for the treatment of localized prostatic cancer. Preliminary results of tolerance and quality of life]V Beckendorf, P Pommier, C Carrie, et al.
Presse Medicale (Paris, France : 1983)|January 15, 2000
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]C Fermé, J M Cosset, B Fervers, et al.
Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric OncologyO Oberlin, G Leverger, H Pacquement, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1986
Abdominal recurrences in Wilms' tumours: a report from the SIOP Wilms' tumour trials and studiesJ M Burgers, M F Tournade, P Bey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Management of mucositis following radiotherapy for head and neck cancers]M Lapeyre, C Charra-Brunaud, M C Kaminsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815)W A Van Sickle, P K Wilson, M W Wannamaker, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 30, 2010
[Is proton beam therapy the future of radiotherapy? Part I: clinical aspects]A Bouyon-Monteau, J-L Habrand, J Datchary, et al.
Journal of Medicinal Chemistry|February 1, 1991
4',5'-unsaturated 5'-halogenated nucleosides. Mechanism-based and competitive inhibitors of S-adenosyl-L-homocysteine hydrolaseE T Jarvi, J R McCarthy, S Mehdi, et al.
British Journal of Cancer|May 18, 2001
Hodgkins diseaseC Ferme, J M Cosset, B Fervers, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Multicenter study on dose escalation with conformal and conventional radiotherapy for the treatment of localized prostatic cancer. Preliminary results of tolerance and quality of life]V Beckendorf, P Pommier, C Carrie, et al.
Presse Medicale (Paris, France : 1983)|January 15, 2000
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]C Fermé, J M Cosset, B Fervers, et al.
Oncology Reports|October 14, 1998
Treatment of subdiaphragmatic Hodgkin's disease: long-term results and side effectsB Cutuli, T Petit, S Hoffstetter, et al.
Pageof 18